virus leukemia
Recently Published Documents


TOTAL DOCUMENTS

43
(FIVE YEARS 0)

H-INDEX

8
(FIVE YEARS 0)

2002 ◽  
Vol 76 (6) ◽  
pp. 2912-2923 ◽  
Author(s):  
Jean-Luc Guerin ◽  
Jacqueline Gelfi ◽  
Severine Boullier ◽  
Maxence Delverdier ◽  
Frederique-Anne Bellanger ◽  
...  

ABSTRACT Down-modulation of major histocompatibility class I (MHC-I) molecules is a viral strategy for survival in the host. Myxoma virus, a member of the Poxviridae family responsible for rabbit myxomatosis, can down-modulate the expression of MHC-I molecules, but the viral factor(s) has not been described. We cloned and characterized a gene coding for an endoplasmic reticulum (ER)-resident protein containing an atypical zinc finger and two transmembrane domains, which we called myxoma virus leukemia-associated protein (MV-LAP). MV-LAP down-regulated surface MHC-I and Fas-CD95 molecules upon transfection; the mechanism probably involves an exacerbation of endocytosis and was lost when the ER retention signal was removed. In addition, the lytic activity of MHC-I-restricted antigen-specific cytolytic T lymphocytes (CTL) against myxoma virus-infected antigen-presenting target cells was significantly reduced, revealing a strong correlation between MHC-I down-regulation by MV-LAP and CTL killing in vitro. In vivo experiments with a knockout virus showed that MV-LAP is a virulence factor, potentially involved in the immunosuppression characteristic of myxomatosis. Data bank analysis revealed that MV-LAP has homologs in herpesviruses and other poxviruses. We propose the name “scrapins” to define a new group of ER-resident surface cellular receptor abductor proteins. The down-regulation of cell surface molecules by scrapins probably helps protect infected cells during viral infections.


1998 ◽  
Vol 3 (1) ◽  
pp. 8-10
Author(s):  
Charles L. Baldwin ◽  
Robert S. Runkle

The need for a symbol to warn of potential infection hazards became apparent during Public Health Service contract work on the development of containment facilities for virus-leukemia research. A program of direct inquiry and a search of the literature revealed that there was no universally used signal and that scientific and safety organizations concurred in the need for one. Criteria for symbol design were established, and final section was based on “uniqueness” and “memorability.” The National Institutes of Health is recommending use of the symbol as a warning of biological hazard.


1992 ◽  
Vol 673 (1 Physiopatholo) ◽  
pp. 46-52 ◽  
Author(s):  
PETER EBBESEN ◽  
JAN A. VILLADSEN ◽  
HENRIK D. VILLADSEN ◽  
KNUD E. HELLER

Sign in / Sign up

Export Citation Format

Share Document